Uzma Samadani

USPTO Granted Patents = 14 (Patent Applications = 11)

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 6)

Average Co-Inventor Count = 1.7

ph-index = 4

Forward Citations = 59(Granted Patents)

Location History:

New York, NY (US) (2017 - 2022)
Minneapolis, MN (US) (2020 - 2024)
Wayzata, MN (US) (2023 - 2024)

Company Filing History:

The United States Government As Represented by the Department of Veterans Affairs

patents

3 out of 3

Hennepin Healthcare System, Inc

patents

4. 1 out of 1

Hennepin Healthcare Systems, Inc.

patent

where one patent can have more than one assignee

Years Active: 2017-2025

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12201361 - Methods and kits for assessing central nervous system integrity (2025-01-21),

2. 12161415 - Method for predicting convergence disorders caused by concussion or other neuropathology (2024-12-10),

3. 11944449 - Methods and kits for assessing neurological function and localizing neurological lesions (2024-04-02),

4. 11937935 - Methods and kits for detection of blast brain injury, its severity, distance from blast epicenter, and classification relative to the larger spectrum of concussion (2024-03-26),

5. 11883118 - Using augmented reality in surgical navigation (2024-01-30),

6. 11642071 - Methods and kits for assessing neurological function and localizing neurological lesions (2023-05-09),

7. 11304601 - Methods and kits for assessing central nervous system integrity (2022-04-19),

8. 11064881 - Method for predicting convergence disorders caused by concussion or other neuropathology (2021-07-20),

9. 11013441 - Methods and kits for diagnosing, assessing or quantitating drug use, drug abuse and narcosis, internuclear ophthalmoplegia, attention deficit hyperactivity disorder (ADHD), chronic traumatic encephalopathy, schizophrenia spectrum disorders and alcohol consumption (2021-05-25),

10. 10966669 - Methods and kits for assessing neurological and ophthalmic function and localizing neurological lesions (2021-04-06),

11. 10657642 - System, method and computer-accessible medium for the determination of accelerated brain atrophy and an optimal drainage site for a subdural hematoma using computed tomography (2020-05-19),

12. 10610165 - Methods and kits for assessing neurological and ophthalmic function and localizing neurological lesions (2020-04-07),

13. 10219694 - Methods and kits for assessing central nervous system integrity (2019-03-05),

14. 9642522 - Methods and kits for assessing central nervous system integrity (2017-05-09),

Title: Innovative Contributions of Uzma Samadani in Eye Tracking Technology

Introduction

Uzma Samadani, an accomplished inventor based in New York, NY, has made significant strides in the field of eye tracking technology and its applications in diagnosing neurological conditions. With a remarkable portfolio of 14 patents, her work is pivotal in advancing our understanding of central nervous system integrity and brain injury assessment.

Latest Patents

Uzma's latest inventions focus on methods and kits for assessing central nervous system integrity. One notable patent involves a sophisticated eye tracker equipped with a camera that monitors eye movements. This system uses a processor to create a dataset reflecting the timecourse of eye position versus time, identifying vertical streaking lines that indicate deficits in cranial nerve II function. Additionally, she developed a method for predicting convergence disorders that may result from concussion or other neuropathological conditions. This method tracks eye movement to generate data used to determine abnormal eye convergence, ultimately aiding in the diagnosis of brain injuries.

Career Highlights

Throughout her career, Uzma Samadani has worked with prestigious institutions, including New York University and the Department of Veterans Affairs, representing the United States of America. Her innovative research has paved the way for improved diagnostic tools that can detect and analyze eye movement abnormalities, significantly contributing to both clinical practices and innovative technologies in neuro-optometry.

Collaborations

Uzma has collaborated with talented professionals such as Abdullah Bin Zahid and Shani Offen. Their collective expertise has fostered a dynamic research environment, enhancing the development of technologies aimed at better understanding and diagnosing eye movement disorders.

Conclusion

Uzma Samadani's contributions to the field of eye tracking are invaluable, with her 14 patents standing as a testament to her innovative spirit. Her work not only advances medical science but also showcases the intersection of technology and healthcare, promising improvements in patient diagnosis and treatment. Through ongoing research and collaboration, Uzma continues to influence developments in eye tracking technology, aiming to enhance the quality of care for individuals impacted by neurological disorders.

This text is generated by artificial intelligence and may not be accurate.